Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,116
Closed -$225K 172
2022
Q2
$225K Sell
4,116
-240
-6% -$13.2K 0.08% 145
2022
Q1
$238K Sell
4,356
-160
-4% -$8.69K 0.07% 144
2021
Q4
$248K Sell
4,516
-232
-5% -$12.1K 0.07% 139
2021
Q3
$230K Buy
+4,748
New +$238K 0.08% 139

Other funds holding GSK

WNY Asset Management's GSK Position: Q3 2022 in Review

WNY Asset Management sold out of GSK (GSK) in Q3 2022, closing a stake of 4,116 shares — an estimated $225K sold.

WNY Asset Management first reported a position in GSK in Q3 2021 and held it in 4 quarters. The position peaked at $248K in Q4 2021. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

  • WNY Asset Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
  • WNY Asset Management sold 4,116 GSK shares in Q3 2022, an estimated $225K.
  • WNY Asset Management first reported a position in GSK in Q3 2021 and held it in 4 quarters.
  • WNY Asset Management's GSK position peaked at $248K in Q4 2021.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on WNY Asset Management's 13F filing for Q3 2022, filed 25 Oct 2022.